CVSD Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$48.45 |
| 52 Week High | US$68.12 |
| 52 Week Low | US$48.45 |
| Beta | 0.54 |
| 1 Month Change | -6.92% |
| 3 Month Change | n/a |
| 1 Year Change | -28.88% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSD | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -1.5% |
| 1Y | -28.9% | -24.7% | 3.5% |
Return vs Industry: CVSD underperformed the UK Healthcare industry which returned -24.7% over the past year.
Return vs Market: CVSD underperformed the UK Market which returned 3.5% over the past year.
Price Volatility
| CVSD volatility | |
|---|---|
| CVSD Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CVSD's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine CVSD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVSD fundamental statistics | |
|---|---|
| Market cap | €54.91b |
| Earnings (TTM) | €4.83b |
| Revenue (TTM) | €353.88b |
11.4x
P/E Ratio0.2x
P/S RatioIs CVSD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSD income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVSD perform over the long term?
See historical performance and comparisonDividends
5.9%
Current Dividend Yield66%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:36 |
| End of Day Share Price | 2024/12/12 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CVS Health Corporation is covered by 63 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Samuel Hudson | Atlantic Equities LLP |